Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.
Adcock DM, Kressin DC, Marlar RA
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of sodium citrate concentration and assay reagent on PT and aPTT in plasma from healthy volunteers and patients on anticoagulant therapy.
Summary of Findings
When the responsive reagents (Actin FS and Innovin) were used, the normal ranges of aPTT and PT increased when specimens from healthy volunteers were collected in 3.8% citrate compared to 3.2% citrate (both p<0.001). There was no significant difference in aPTT or PT ranges between specimens from healthy volunteers collected in 3.8 or 3.2% citrate when the nonresponsive reagents (Actin and Thromboplastin C+) were used in the assays. Specimens collected from all four treatment groups (no anticoagulant, IV heparin, oral anticoagulants, or both anticoagulant therapies) into 3.8% citrate had significantly higher PT values than those collected into 3.2% citrate with Innovin. When Thromboplastin C+ was used, only the IV heparin therapy treatment group had longer PT when collected in 3.8% rather than 3.2% citrate. Specimens collected from all four treatment groups into 3.8% citrate had significantly higher aPTT values than those collected into 3.2% citrate with Actin FS. When Actin was used, this was only true for patients on IV heparin therapy, with or without additional oral anticoagulants.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
None (Fresh)Diagnoses
NormalNot specifiedPlatforms
MorphologyHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Other drugs IV heparinIV heparin and oral anticoagulantsNo anticoagulantsOral anticoagulantsBiospecimen Acquisition Anticoagulant Multiple concentrations evaluatedSodium citrateHematology/ auto analyzer Specific Reaction solution ActinActin FSInnovinThromboplastin C+